Kantonsspital Graubuenden

Chur, Kanton Graubünden 7000

0 studies enrolling now · 1 studies all time

What they study most

Carcinoma, Non-Small-Cell Lung

Studies at this site

• Study of Lorlatinib In People With ALK-positive Non-small Cell Lung Cancer — Completed